FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

NTRA submits FDA PMA for Signatera CDx, aiming to guide bladder cancer treatment with MRD testing after positive phase 3 ...

Quest Diagnostics , a leading provider of diagnostic information services, today announced the launch of a novel blood test that uses advanced flow cytometry methods to assess measurable residual ...

Chugai files regulatory application with MHLF for additional indication of Tecentriq to treat adjuvant therapy for MRD-positive bladder cancer: Tokyo Thursday, January 29, 2026, 0 ...

Japanese drugmaker Chugai today revealed it has filed a regulatory application with the Ministry of Health, Labor and Welfare (MHLW) for the anti-cancer agent/humanized anti-PD-L1 monoclonal antibody ...

After a short delay and concerns of potential intervention from senior officials, the FDA has issued a draft guidance for the industry on the potential use of minimal residual disease (MRD) and ...

Although Microsoft has improved File Explorer over the years, it still doesn't meet modern expectations. You can't open folders side by side, add tags to folders, pin ...

Full year MRD revenue growth of 46% driven by clonoSEQ® testing volumeSEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Adaptive ...

In patients with newly diagnosed multiple myeloma (MM) who are not eligible for stem cell transplant, the regimen of isatuximab plus lenalidomide, dexamethasone, and bortezomib (also known as Isa-VRd) ...

(NEXSTAR) – In 2025, nearly 300,000 Americans used a new electronic system to file their taxes directly with the IRS for free. In 2026, that’s no longer an option. IRS Direct File launched as a pilot ...

Breast cancer relapse often begins long before it can be seen. Tiny clusters of residual tumor cells may persist after treatment, quietly driving recurrence while remaining invisible to conventional ...